已收盤 05-08 16:00:00 美东时间
+0.010
+0.28%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
Gold Royalty Corp. (($GROY)) has held its Q1 earnings call. Read on for the mai...
05-08 09:29
HC Wainwright & Co. analyst Heiko F. Ihle maintains Gold Royalty (AMEX:GROY) with a Buy and raises the price target from $6.75 to $7.75.
05-08 03:09
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
今日重点评级关注:HC Wainwright & Co.:维持Protara Therapeutics"买入"评级,目标价从23美元升至27美元;BTIG:维持Black Diamond Therapeutic"买入"评级,目标价从10美元升至11美元
04-30 19:24
Canaccord Genuity analyst Carey MacRury upgrades Gold Royalty (AMEX:GROY) from Hold to Buy and maintains the price target from $5 to $5.
04-29 23:53
今日重点评级关注:Canaccord Genuity:维持Intellia Therapeutics"买入"评级,目标价从48美元升至58美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从7美元升至8美元
04-29 10:28
Gold Royalty Corp. ("Gold Royalty" or the "Company") (NYSE:GROY) is pleased to announce its preliminary results for the first quarter of 2026 and dates for the release of its results for the first quarter, related
04-27 18:36
VANCOUVER, BC, April 27, 2026 /PRNewswire/ - Gold Royalty Corp. ("Gold Royalty" or the "Company") (NYSE American: GROY) is pleased to announce its preliminary results for the first quarter o...
04-27 18:30
Precious metal companies are trading lower as a stronger dollar and rising yiel...
04-22 01:32